Karsten Schmidt

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

E. Dahl, K. Jöckel, A. Kribben, 2021, Pharmacogenetics and genomics.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation

P. Heuschmann, F. Rosenow, C. Putensen, 2022, Critical Care.

Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

Aleksandar R. Zivkovic, Karsten Schmidt, Thorsten Brenner, 2022, Diagnostics.